NCT03503643

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Cryoablation: An Observational Study of Hemi-Gland Cryoablation Outcomes for Prostate Cancer at University of California at Los Angeles (UCLA)

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Jonsson Comprehensive Cancer Center · Academic / Other
• Sex: Male
• Age: —
• Healthy volunteers: Not accepted

Summary

This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric MRI and Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes.

Conditions

• Prostate Cancer
• Prostate Adenocarcinoma
• Prostate Disease

Interventions

Type	Name	Description
DEVICE	Hemigland Cryoablation	Hemigland cryoablation for the treatment of prostate cancer

Timeline

• Start date: 2017-09-14
• Primary completion: 2024-12-31
• Completion: 2026-12-31
• First posted: 2018-04-20
• Last updated: 2025-05-13

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study